Who funds addiction research?

We count 82 funded addiction projects, active between 2021 and 2032, from 5 funders. The most came from NIH · NIDA (28 projects), EU · ERC (11 projects) and Wellcome (8 projects). The median award is $3.5M, across the 82 of 82 projects that list an amount.

Funded projects

82

Funders

5

Median award

$3.5M

Open calls now

29

Top funders of addiction research

Projects whose title or summary mentions addiction. Median award: of the projects that list an amount, in US dollars; “—” when fewer than 3 do.

Open addiction funding calls

29 open calls mention addiction today; the 12 most on-topic are listed.

• BJA FY 2026 Comprehensive Opioid, Stimulant, and Substance Use Program (COSSUP) Training and Technical Assistance (TTA)
  Bureau of Justice AssistanceUp to $2,000,000Deadline: November 2, 2026 ·
• Crime prevention approaches, online and off-line, tackling the nexus between addictions and crime
  European Commission · Horizon EuropeUp to €3,000,000Deadline: November 5, 2026 ·
• NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)
  National Institutes of HealthUp to $750,000Deadline: November 13, 2026 ·
• OJJDP FY 2026 Mentoring for Youth Impacted by Opioids and Other Substance Use
  Office of Juvenile Justice Delinquency Prevention Up to $2,000,000Deadline: November 16, 2026 ·
• Neural Ensembles & Used Substances (NExUS) Collaboratory: Building a Multimodal Inventory of Cell Ensembles Encoding the Effects of Addictive Substances (U01 Clinical Trial Not Allowed)
  National Institutes of HealthNot specifiedDeadline: February 8, 2027 ·
• High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)
  National Institutes of HealthUp to $1,500,000Deadline: March 5, 2027 ·
• High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)
  National Institutes of HealthNot specifiedDeadline: March 6, 2027 ·
  Real odds: About 1 in 8 funded (13% · NIH R01-equivalent grants, all NIH institutes, FY2025)
• Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)
  National Institutes of HealthNot specifiedDeadline: December 3, 2027 ·
  Real odds: About 1 in 8 funded (13% · NIH R01-equivalent grants, all NIH institutes, FY2025)
• Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)
  National Institutes of HealthNot specifiedDeadline: December 3, 2027 ·
  Real odds: About 1 in 9 funded (11% · NIH R21 (exploratory/developmental), all NIH institutes, FY2025)
• Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)
  National Institutes of HealthNot specifiedDeadline: June 16, 2028 ·
• Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)
  National Institutes of HealthUp to $3,000,000Deadline: August 21, 2028 ·
• Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional)
  National Institutes of HealthNot specifiedDeadline: September 25, 2028 ·

Real odds

• About 1 in 8 funded · 13% · NIH R01-equivalent grants, all NIH institutes, FY2025 · NIH Data Book, report 29
• About 1 in 9 funded · 11% · NIH R21 (exploratory/developmental), all NIH institutes, FY2025 · NIH Data Book, report 202

Published success rates for the programs behind the open calls above: the share of applications the funder funded, program-wide, not for this topic.

Forecast: announced, not open yet

10 forecast calls on addiction. Funders publish forecasts before a call opens; you can't apply to these yet, and dates can change.

• ForecastNIDA Avenir Program: Fundamental Mechanistic Research in Addiction Science
  National Institutes of HealthUp to $375,000Expected to open February 1, 2027
• ForecastA Holistic Approach to Study Non-Addictive Natural Products for Pain Management
  National Institutes of HealthNot specifiedExpected to open February 2, 2027
• ForecastRestoring Joint Health and Function to Reduce Pain (RE-JOIN) 2.0
  National Institutes of HealthNot specifiedExpected to open October 1, 2026
• ForecastProviders Clinical Support System – Universities
  Substance Abuse and Mental Health Services AdminisNot specifiedExpected to open December 15, 2026
• ForecastResidential Treatment for Pregnant and Postpartum Women
  Substance Abuse and Mental Health Services AdminisNot specifiedExpected to open December 15, 2026
• ForecastState Pilot Program for Treatment for Pregnant and Postpartum Women
  Substance Abuse and Mental Health Services AdminisNot specifiedExpected to open December 15, 2026
• ForecastGLS Campus Suicide Prevention
  Substance Abuse and Mental Health Services AdminisNot specifiedExpected to open December 15, 2026
• ForecastBuilding Communities of Recovery
  Substance Abuse and Mental Health Services AdminisNot specifiedExpected to open December 15, 2026

Funded addiction projects

A sample, latest start first, at most three per program.

• The Ohio Valley Node of the Clinical Trials Network
  NIH · NIDA · $7,799,687 · ends 2032
• NIDA Clinical Trials Network: New York Node - Renewal-GY24
  NIH · NIDA · $7,781,460 · ends 2032
• NIDA Clinical Trials Network: New York Node (CTN-0139, CTN-0155, CTN-Biostats)
  NIH · NIDA · $5,143,521 · ends 2032
• PATHS – Psychedelics as Therapeutics: Harm Reduction and Safety
  Wellcome · £2,500,000 · ends 2031
• Dartmouth Clinical and Translational Science Institute
  NIH · NCATS · $4,073,191 · ends 2031
• Advancing Chronic Disease Health Disparities Research: The RCMI at UH
  NIH · NIMHD · $3,242,195 · ends 2030
• Kicking the Habit: Historicising 'Addictive' Sport Sponsorship in Britain, 1965-2025
  Wellcome · £1,696,710 · ends 2030
• Human Chemo-Nociceptor Signaling
  NIH · NINDS · $3,851,810 · ends 2030
• Optimization of spinal cord stimulation parameters to augment the activity of a critical subpopulation of dorsal horn inhibitory neurons and attenuate pain and itch responses
  NIH · NINDS · $3,350,460 · ends 2030
• CaMKK2-Mediated Pain Mechanisms in Post-traumatic Osteoarthritis
  NIH · NIAMS · $3,686,989 · ends 2030

How we count

Funded projects come from public award records (NIH RePORTER, NSF, EU CORDIS, UKRI Gateway to Research, Wellcome, the Gates Foundation, DOE, NASA and USDA NIFA) whose title or summary matches “addiction or substance use”. NIH lists each budget year separately; one project counts once. Amounts are as the funder lists them; medians use only projects that list one, in US dollars. Open calls and forecasts are from our listings of October 28, 2026. A project can mention a topic without being mainly about it, so treat the counts as a guide to who funds the area.